Moderna tests Next-Gen COVID shots against evolving virus
NCT ID NCT06585241
Summary
This study is testing updated versions of Moderna's COVID-19 vaccine designed to protect against newer virus variants. It will enroll about 1,144 people, including adults, older adults, and children with certain health risks, to see how well the new shots trigger an immune response and how safe they are. The goal is to gather data to help keep vaccines effective as the virus changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel
RECRUITINGAtlanta, Georgia, 30331, United States
-
CenExel
RECRUITINGDecatur, Georgia, 30030, United States
-
Richard Bennett - Clinical Research Partners
RECRUITINGRichmond, Virginia, 23226, United States
-
Velocity Clinical Research
RECRUITINGBaton Rouge, Louisiana, 70809, United States
-
Velocity Clinical Research
RECRUITINGGulfport, Mississippi, 39503, United States
-
Velocity Clinical Research
RECRUITINGOmaha, Nebraska, 68134, United States
Conditions
Explore the condition pages connected to this study.